Enhanced chemotherapeutic toxicity of cyclodextrin templated size-tunable rhodamine 6G nanoGUMBOS
- 20 August 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 6 (34) , 5451-5459
Abstract
Nanodrugs have been widely investigated for combating the large number of side effects associated with conventional therapeutics. Several investigations of such nanomedicines have demonstrated the profound role of nanoparticle size in therapeutic efficacy. Herein, we report the role of cyclodextrin (CD)-templating on the size and therapeutic properties of rhodamine 6G (R6G) nanoGUMBOS, i.e. nanomaterials derived from a Group of Uniform Materials Based on Organic Salts (GUMBOS). In these studies, templating of nanoGUMBOS using 2-hydroxypropyl-alpha (2-HP-α), 2-hydroxypropyl beta (2-HP-β), and gamma (γ) cyclodextrin (CD) led to a significant reduction in size and enhanced uniformity as indicated by transmission electron microscopy (TEM) images. In addition, CD-templated nanoGUMBOS remarkably displayed a three to four fold enhancement in toxicity towards cancer cells as compared to nanoGUMBOS without CD-templates, suggesting a significant improvement in therapeutic efficacy. Correlation between size and toxicity suggests that CD-templated nanoparticles of ∼70 to 80 nm produced optimal toxicity. Even more interesting, all investigated nanoGUMBOS displayed no toxicity toward normal cells under examined conditions. Moreover, these nanoGUMBOS display comparable chemotherapeutic toxicity to the parent dye, [R6G][Cl], while also eliminating toxicity towards normal cells, indicating their strong chemotherapeutic potential. The studies outlined here provide further insight into an approach that may be employed for rapid synthesis of size tunable nanodrugs for enhanced chemotherapeutic efficacy.Keywords
Funding Information
- National Science Foundation (CHE-1508726)
This publication has 43 references indexed in Scilit:
- Synergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cellsCancer Cell International, 2013
- Low concentrations of Rhodamine-6G selectively destroy tumor cells and improve survival of melanoma transplanted miceNeoplasma, 2013
- Understanding and controlling gold nanoparticle formation from a robust self-assembled cyclodextrin solid templateJournal of Materials Chemistry, 2012
- Controlling drug nanoparticle formation by rapid precipitationAdvanced Drug Delivery Reviews, 2011
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Cyclodextrins in delivery systems: ApplicationsJournal of Pharmacy and Bioallied Sciences, 2010
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicinesJournal of Drug Targeting, 2007
- Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆Advanced Drug Delivery Reviews, 2006
- Cyclodextrins and their uses: a reviewProcess Biochemistry, 2004